Header Logo

Connection

Weiyi Peng to Receptor-Interacting Protein Serine-Threonine Kinases

This is a "connection" page, showing publications Weiyi Peng has written about Receptor-Interacting Protein Serine-Threonine Kinases.
  1. Development of a RIPK1 degrader to enhance antitumor immunity. Nat Commun. 2024 Dec 16; 15(1):10683.
    View in: PubMed
    Score: 0.231
  2. Integrating genome-wide CRISPR immune screen with multi-omic clinical data reveals distinct classes of tumor intrinsic immune regulators. J Immunother Cancer. 2021 02; 9(2).
    View in: PubMed
    Score: 0.177
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.